EICHOR
● Completed
The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
Condition: Plaque Psoriasis · Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
About this study
This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 2 doses of TLL018 as therapy in approximately 90 participants with moderate-to-severe PP.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (35)
| Cahaba | Birmingham, Alabama, United States | — |
| Moy, Fincher, Chipps | Beverly Hills, California, United States | — |
| Metropolis Derm | Los Angeles, California, United States | — |
| Amicis Research Center | Northridge, California, United States | — |
| Integrative Skin | Sacramento, California, United States | — |
| Skin Surgical | San Diego, California, United States | — |
| Life Clinical Trials | Coral Springs, Florida, United States | — |
| Palm Beach | DeLand, Florida, United States | — |
| D&H Doral Research Center LLC | Doral, Florida, United States | — |
| Sweet Hope Research Specialty, Inc | Hialeah, Florida, United States | — |
| CNS - Jacksonville | Jacksonville, Florida, United States | — |
| CNS - Orlando SODO | Jacksonville, Florida, United States | — |
+ 23 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05772520